Beata Olejnicka
Overview
Explore the profile of Beata Olejnicka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Janciauskiene S, Lechowicz U, Pelc M, Olejnicka B, Chorostowska-Wynimko J
Biomed Pharmacother
. 2024 Apr;
175:116618.
PMID: 38678961
SERPIN (serine proteinase inhibitors) is an acronym for the superfamily of structurally similar proteins found in animals, plants, bacteria, viruses, and archaea. Over 1500 SERPINs are known in nature, while...
2.
Sivaraman K, Liu B, Martinez-Delgado B, Held J, Buttner M, Illig T, et al.
Lung
. 2024 Mar;
202(2):157-170.
PMID: 38494528
Purpose: To investigate the transcriptome of human bronchial epithelial cells (HBEC) in response to serum from patients with different degrees of inflammation. Methods: Serum from 19 COVID-19 patients obtained from...
3.
Borner F, Lechowicz U, Wrenger S, Martinez-Delgado B, Olejnicka B, Welte T, et al.
ERJ Open Res
. 2023 Dec;
9(6).
PMID: 38076674
https://bit.ly/3rNJeLd.
4.
Sivaraman K, Pino P, Raussin G, Anchisi S, Metayer C, Dagany N, et al.
Microorganisms
. 2023 Nov;
11(11).
PMID: 38004695
Intracellular lipid droplets (LDs) can accumulate in response to inflammation, metabolic stresses, and other physiological/pathological processes. Herein, we investigated whether spike proteins of SARS-CoV-2 induce LDs in human peripheral blood...
5.
Al-Omari M, Al-Omari T, Batainah N, Al-Qauod K, Olejnicka B, Janciauskiene S
BMC Cancer
. 2023 Aug;
23(1):722.
PMID: 37532996
Background: It is widely accepted that chronic inflammatory bowel diseases significantly higher a risk for colorectal cancer development. Among different types of treatments for patients with colon cancer, novel protein-based...
6.
Stanke F, Janciauskiene S, Olejnicka B
Front Pharmacol
. 2023 Feb;
14:1145990.
PMID: 36817143
No abstract available.
7.
Beimdiek J, Janciauskiene S, Wrenger S, Volland S, Rozy A, Fuge J, et al.
Respir Res
. 2022 Dec;
23(1):343.
PMID: 36514048
Background: SARS-CoV-2 infected patients show heterogeneous clinical presentations ranging from mild symptoms to severe respiratory failure and death. Consequently, various markers reflect this wide spectrum of disease presentations. Methods: Our...
8.
Janciauskiene S, Tumpara S, Schebb N, Buettner F, Mainka M, Sivaraman K, et al.
Front Pharmacol
. 2022 Oct;
13:995869.
PMID: 36249781
Human alpha-1-antitrypsin (AAT) encoded by the gene, is an acute phase glycoprotein that regulates inflammatory responses both protease inhibitory and non-inhibitory activities. We previously reported that AAT controls ATP-induced IL-1β...
9.
Sark A, Fromme M, Olejnicka B, Welte T, Strnad P, Janciauskiene S, et al.
Biomolecules
. 2022 Mar;
12(3).
PMID: 35327571
Alpha-1-Antitrypsin (AAT) is a protein of the SERPINA1 gene. A single amino acid mutation (Lys342Glu) results in an expression of misfolded Z-AAT protein, which has a high propensity to intra-...
10.
Tumpara S, Grunding A, Sivaraman K, Wrenger S, Olejnicka B, Welte T, et al.
Int J Mol Sci
. 2021 Aug;
22(15).
PMID: 34360706
For the treatment of severe COVID-19, supplementation with human plasma-purified α-1 antitrypsin (AAT) to patients is currently considered. AAT inhibits host proteases that facilitate viral entry and possesses broad anti-inflammatory...